Control of SNARE-mediated granule fusion in mast cells

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Asthma is an allergic disease affecting two million Australians. A major player in asthma is the mast cell which releases histamine when the cell is stimulated by antigen. The process by which histamine is released involves fusion of cytoplasmic granules containing the histamine with the cell surface membrane. The mechanism of this fusion process appears to be different in mast cells compared with other cells studied, raising the possibility that release of histamine, and hence the acute allergic response, could be controlled if more were understood about the fusion process. This project aims to define the mechanism by which granules dock and then fuse with the cell surface. These are the two apects most likely to be unique in mast cells.

Funded Activity Details

Start Date: 01-01-2001

End Date: 01-01-2003

Funding Scheme: NHMRC Project Grants

Funding Amount: $196,527.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biochemistry And Cell Biology Not Elsewhere Classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Allergy | Anaphylaxis | Asthma | Munc18 | SNARE fusion | Secretion | Syntaxin | Tethering and docking | Urticaria